Dabrafenib Mesylate

CAS: 1195768-06-9

Ref. TR-D101005

Produktinformation

• Name: Dabrafenib Mesylate
• Synonyme: Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-, methanesulfonate (1:1), GSK 2118436 methanesulfonate salt, GSK 2118436B, N-[3-[5-(2-Aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide methanesulfonic acid, GSK 2118436B
• CAS: 1195768-06-9

Beschreibung

Stability Hygroscopic
Applications Dabrafenib is an inhibitor of mutated BRAF kinase and has clinical activity with a manageable safety profile in clinical trials of phase 1 and 2 in patients with BRAF(V600)-mutated metastatic melanoma.
References Hauschild, A., et al.: Lancet, 380, 358 (2012); Falchook, G.S., et al.: Lancet, 379, 1893 (2012); Ascierto, P.A., et al.: J. Clin. Oncol., 31, 3205 (2013)

• Marke: TRC

Chemische Eigenschaften

• Molekulargewicht: 615.67
• Formel: C₂₄H₂₄F₃N₅O₅S₃
• Farbe/Form: White
• InChl: InChI=1S/C23H20F3N5O2S2.CH4O3S/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25;1-5(2,3)4/h4-11,31H,1-3H3,(H2,27,28,29);1H3,(H,2,3,4)
• InChI Key: InChIKey=YKGMKSIHIVVYKY-UHFFFAOYSA-N
• SMILES: CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1.CS(=O)(=O)O